What is Cyclacel Pharmaceuticals Inc Annual Revenue?

Cyclacel Pharmaceuticals Inc Annual Revenue fell 89.76%, in the last year to $0.04 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Cyclacel Pharmaceuticals Inc Annual Net Profit?

Cyclacel Pharmaceuticals Inc Annual Net Profit rose 50.29% in the last year to $11.21 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Cyclacel Pharmaceuticals Inc Price to Earning Ratio?

Cyclacel Pharmaceuticals Inc Price to Earning Ratio is -4.75, which is negative.

What is Cyclacel Pharmaceuticals Inc Stock Price?

Cyclacel Pharmaceuticals Inc Stock Price fell 96.05% and underperformed its sector by 121.1% in the past year.

What is Cyclacel Pharmaceuticals Inc Quarterly Net profit?

Cyclacel Pharmaceuticals Inc Quarterly Net profit rose 97.25% YoY to $0.08 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Cyclacel Pharmaceuticals Inc Mutual Fund Holding?

Cyclacel Pharmaceuticals Inc Mutual Fund Holding increased by 0.02% in the last quarter to 0.73.

What is Cyclacel Pharmaceuticals Inc Promoter Share Holding?

Cyclacel Pharmaceuticals Inc Promoter Share Holding stayed the same in the most recent quarter at 0.08%.

What is Cyclacel Pharmaceuticals Inc Institutional Holding?

Cyclacel Pharmaceuticals Inc Institutional Holding decreased by 0.01% in the last quarter to 0.33.

Cyclacel Pharmaceuticals Inc XNAS: CYCC

Cyclacel Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Cyclacel Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Cyclacel Pharmaceuticals Inc
Rating: 0.40558325
Author: Trendlyne DVM scores

about

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including C...

1.67 0.03 (1.83%)

95.94% Fall from 52W High

88,170 XNAS Volume

XNAS 03 Jun, 2025 4:18 PM (EDT)

Not Eligible

-

Expensive Valuation

0.3 / 100

Technically Bearish

15.9 / 100

1

1Yr Price target downside is -40%

1 analysts

Cyclacel Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cyclacel Pharmaceuticals Inc FAQ

How is Cyclacel Pharmaceuticals Inc today?

Cyclacel Pharmaceuticals Inc today is trading in the green, and is up by 1.83% at 1.67.

How has Cyclacel Pharmaceuticals Inc performed historically?

Cyclacel Pharmaceuticals Inc is currently trading up 1.83% on an intraday basis. In the past week the stock rose 15.17%. stock has been down -68.55% in the past quarter and fell -96.05% in the past year. You can view this in the overview section.